Sign in

CIK 0001609809

  • Non-accelerated filer
  • Smaller reporting company

Seres Therapeutics, Inc.

Sign in to watch
Ticker
MCRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
274326290
Phone
+1 617-945-9626
Business address
200 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
Seres Therapeutics, Inc., Seres Health, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4/A Open-market sale Chief Technology Officer & EVP sold 18,640 shares at $31.94 ($595,362)
  7. 4 Open-market sale Chief Technology Officer & EVP sold 9,390 shares at $10.87 ($102,069)
  8. 4 Open-market sale Chief Technology Officer & EVP sold 9,250 shares at $35.00 ($323,750)
  9. 4 Open-market sale Chief Medical Officer and EVP sold 4,156 shares at $35.18 ($146,207)
  10. 4 Open-market sale President and CEO sold 20,000 shares at $35.00 ($700,000)
  11. 4 Open-market sale Chief Medical Officer and EVP sold 38,064 shares at $35.14 ($1,337,512)
  12. 4 Open-market sale Chief Technology Officer & EVP sold 9,390 shares at $34.18 ($320,950)
  13. 4 Open-market sale President and CEO sold 88,211 shares at an average $29.45 ($2,597,474)
  14. 4 Open-market sale President and CEO sold 56,789 shares at an average $29.81 ($1,692,705)
  15. 4 Open-market sale CFO and EVP sold 4,533 shares at $29.54 ($133,905)
  16. 4 Open-market sale Chief Technology Officer & EVP sold 9,390 shares at $27.23 ($255,690)
  17. 4 Open-market sale CFO and EVP sold 5,001 shares at an average $28.28 ($141,445)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 16 of 19 · 380 filings